Explanation of the domestic price and cost budget of taking Ribociclib for one year

Ribociclib, also known as Ribociclib, is a targeted therapy drug mainly used to treat HR-positive, HER2-negative advanced or metastatic breast cancer. Domestically, the drug has received marketing approval and has been successfully included in the medical insurance reimbursement list. The current common domestic specifications are 200mg*63 tablets per box, and the selling price after medical insurance may be around 4000 multiple yuan. According to the recommended medication regimen, patients usually take 21 days every 21 days and stop 7 days. One course of treatment requires 63 tablets, so a box of pills can roughly last a course of treatment.

If calculated based on the monthly use of one box of Riboxil, the out-of-pocket price after medical insurance is about 4,000 yuan, then the total cost of medication for 12 months is about 4.8 yuan. This cost is relatively controllable, especially for breast cancer patients who take long-term medication. With the support of medical insurance, the financial burden is greatly reduced. However, the specific reimbursement ratio needs to be determined according to local medical insurance policies. It is recommended that patients consult the local hospital pharmacy or medical insurance center for detailed cost details.

In overseas markets, the price of Riboxil’s original drug is significantly higher than that in China. Taking the European version as an example, a box of common 200mg63 tablets can cost more than 20,000 yuan. Even the original version produced in India costs more than 2,000 yuan for the same specifications. The generic drugs launched by Lucius Pharmaceuticals in Laos are more affordable, with 200mg21 tablets priced at about more than one thousand yuan per box. However, since these drugs involve cross-border purchases, attention must be paid to the compliance of the channels and the authenticity of the drugs.

Taken together, if the patient chooses to take the drug within domestic medical insurance, the annual treatment cost of Riboxil is within a reasonable range. For patients without medical insurance support or who want to save costs, they can also consider overseas generic drugs, but they must be obtained through formal channels to ensure efficacy and safety. During use, liver function and electrocardiogram should also be reviewed regularly to ensure the long-term safety of the medication.

Reference materials:https://us.kisqali.com/